Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows: – Collaboration revenue (79.8%); – Grant revenue (20.2%).
https://www.marketscreener.com/quote/stock/MODERNA-INC-47437573/